% Expired Patents = 80.0

Forward Citations = 20

Loading Chart...

3 inventors (with patents filed for the assignee):

Edwin S C Wu (5 out of 8 patents)

Mao-Hsiung Yen (5 out of 9 patents)

Chin-Tsai Fan (3 out of 4 patents)

5 patents: Sort by Forward Citations

1. 8404706 - Opioid and opioid-like compounds and uses thereof (2013-03-26),

2. 8138165 - Chromones and chromone derivatives and uses thereof (2012-03-20),

3. 8017622 - Opioid and opioid-like compounds and uses thereof (2011-09-13),

4. 7923454 - Opioid and opioid-like compounds and uses thereof (2011-04-12),

5. 7501433 - Opioid and opioid-like compounds and uses thereof (2009-03-10),

Company Overview

Jenken Biosciences, Inc. is a leading biotechnology company specializing in innovative research and development of pharmaceutical products. With a focus on biologics and personalized medicine, Jenken Biosciences is dedicated to advancing healthcare through cutting-edge technology and scientific advancements. Our team of experts works tirelessly to develop novel therapies for various diseases and conditions, with a commitment to improving the quality of life for patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#37 in Cary, NC

#1,124 in North Carolina

#51,644 in US

Cary, NC, United States of America

Jenken Biosciences, Inc.

Forward Citations = 20

3 inventors:

Edwin S C Wu (5 out of 8 patents)

Mao-Hsiung Yen (5 out of 9 patents)

Chin-Tsai Fan (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Jenken Biosciences, Inc.. Retrieved from https://idiyas.com/company/jenken-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]